Rebamipide Tablets

Function:
Gastric ulcer.

Dosage:
Gastric ulcer: Usually adults take 0.1g (1 tablet) at a time, 3 times a day, orally in the morning, evening and before going to bed. Improvement of gastric mucosal lesions (erosion, bleeding, congestion, edema) in the acute exacerbation phase of acute gastritis and chronic gastritis: Usually adults take 0.1g (1 tablet) at a time, 3 times a day, orally.

Adverse reactions:
Serious adverse reactions: leukopenia (less than 0.1%), thrombocytopenia (unknown frequency). Sometimes leukopenia and thrombocytopenia occur. At this time, full observation should be carried out. If abnormalities are found, administration should be suspended and appropriate treatment should be carried out. Liver dysfunction (less than 0.1%), jaundice (unknown frequency). Liver dysfunction and jaundice, such as increased GOT, GPT, γ-GTP, and AL-P, sometimes occur. At this time, adequate observation should be carried out. If abnormalities are found, administration should be suspended and appropriate treatment should be taken. General adverse reactions: allergic reactions: rash, itching, drug eruption-like eczema. Transaminase increases significantly, or symptoms such as fever and rash occur simultaneously.

Drug contraindications:
If you are allergic to this product, use with caution during pregnancy. Use with caution during lactation. Use with caution if you have liver and kidney dysfunction.